Albert E. Jergens, D.V.M., Ph.D. , Iowa State University, ($100,000) for his project entitled Inheritance of inflamed microbiota confers increased susceptibility to colitis.

Sean Fielding Brady, Ph.D., Rockefeller University ($100,000) for his project entitled Investigating the role of gut microbiota secondary metabolism in IBD – a path to novel IBD therapeutics.

James D. Lord, M.D., Ph.D., Benaroya Research Institute ($100,000) for his project entitled Identifying and Characterizing T cell Immunity to Specific Intestinal Bacterial Antigens in Crohn’s Disease Through MHC-II Tetramer.

Jeffrey C. Rathmell, Ph.D., Duke University Medical Center ($100,000) for his project entitled Metabolic Control of T Cell Subsets and Pyruvate Dehydrogenase Kinase as a Target in Inflammatory Bowel Disease.

Alexander V.Chervonsky, M.D., Ph.D., The University of Chicago ($100,000) for his project entitled  Epithelial fucosylation, microbiota and IBD.

Jose Henrique Veiga Fernandes, D.V.M, Ph.D., Instituto de Medicina Molecular ($100,000) for his project entitled Control of innate lymphoid cells and intestinal homeostasis by neurotrophic factors.

Bing Xu, Ph.D., Brandeis University ($100,000) for his project entitled Nanofibers of self-assembled de novo glycoconjugates for mucosal lining restoration and anti-inflammatory drug delivery.